Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma

Gynecologic Oncology

Volumn 70, Issue 2, 1998, Pages 165-171

  Mohan, Dasarahally S ^b   Samuels, Michael A ^b   Selim, Mostafa A ^b   Shalodi, Abdelwahab D ^b   Ellis, Rodney J ^b   Samuels, Judith R ^b   Yun, Hyun J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Brachytherapy; Endometrial carcinoma; Lymphadenectomy; Morbidity

Indexed keywords

ABDOMINAL HYSTERECTOMY; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EARLY CANCER; ENDOMETRIUM CARCINOMA; LYMPH NODE METASTASIS; MORBIDITY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME;

EID: 0032142785     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5098     Document Type: Article

References (14)

1. Cancer Facts and Figures - 1997, American Cancer Society, Atlanta, Georgia, 1997.
2. Creasman W, Morrow C, Bundy B, Homesley H, Graham J, Heller P. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 60:1987;2035-2041.
3. Kilgore L C, Partridge E E, Alvarez R D, Austin Maxwell J, Shingleton H M, Noojin F III, Conner W. Adenocarcinoma of the endometrium - survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 56:1995;29-33.
4. Lewandoski G, Torrisi J, Potkul R K, Holloway R W, Popescu G, Whitfield G, Delgado G. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer - a comparison of complication rates. Gynecol Oncol. 36:1990;401-404.
5. Orr J W Jr, Holimon J L, Orr P F. Stage I corpus cancer - is teletherapy necessary. Am J Obstet Gynecol. 176:1997;4,777-789.
6. Announcement, FIGO stages. 1988 revisions. Gynecol Oncol. 35:1989;125-127.
7. DiSaia P J, Creasman W T, Boronow R C, Blessing J A. Risk factors and recurrence patterns in stage I endometrial cancer. Am J Obstet Gynecol. 151:1985;1009-1015.
8. Lewis B V, Stallworthy J A, Cowdell R. Adenocarcinoma of the body of the uterus. J Obstet Gynaecol Br Comm. 77:1970;343-348.
9. Boronow R C, Morrow C P, Creasman W T, DiSaia P J, Silverberg S G, Miller A, Blessing J A. Surgical staging in endometrial cancer - clinical-pathologic findings of a prospective study. Obstet Gynecol. 63:1984;825-832.
10. Potish R A, Dusenbury K E. Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Oncol Biol Phys. 18:1990;1005-1010.
11. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma - a prospective clinical trial of 605 patients who received vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 38:1990;99-104.
12. Marchetti D L, Caglar H, Driscoll D L, Hreshchshyn M M. Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes. Gynecol Oncol. 37:1990;51-54.
13. Creasman W T, Boronow R C, Morrow C P, DiSaia P J, Blessing J. Adenocarcinoma of the endometrium - its metastatic lymph node potential. Gynecol Oncol. 4:1976;239-243.
14. Eltabbakh G H, Piver M S, Hempling R E, Shin K H. Excellent long term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Oncol Biol Phys. 38:1997;2,373-380.